Vivera Pharmaceuticals Partners with EcoGroup USA in the Distribution of its BioZone Sanitizing Stations
“Saving Lives is Our Goal and Passion”, Gregory Shiffner, CEO of EcoGroup USA
NEWPORT BEACH, Calif., Nov. 18, 2020 /PRNewswire/— Vivera Pharmaceuticals is excited to announce a distribution partnership with EcoGroup USA for Vivera’s BioZone, an advanced access control device intended for sanitization in high occupancy settings. BioZone is designed to combine facial recognition, integrated biometrics, and a hospital-grade FDA and EPA-approved organic sanitization mist (OSM) to provide a completely integrated solution for high occupancy and high traffic settings. It can be customized to address the specific and diverse needs of different facilities.
Vivera Pharmaceuticals’ CEO, Paul Edalat said, “Technology like BioZone is central to closing the gap between restoring safety and instilling confidence in workplaces and public venues again. An integrated solution, BioZone allows for maximum flexibility in how back to work or back to school protocols are set. BioZone is an additional piece to the overall puzzle, and Vivera is looking forward to working with EcoGroup USA on expanding the reach of COVID-19 solutions.”
This statement from Mr. Edalat reiterates EcoGroup USA’s mission in providing solutions for a safe and healthy work environment to all businesses. Dr. Harold Haines Ph.D., Chief Technology Officer of EcoGroup USA, added, “We welcome the addition of Vivera Pharmaceuticals into EcoGroup USA’s growing list of American and International partners who contribute new and innovative products, services, and technologies, which strengthen and expand our existing solutions for preventing and controlling the spread of infectious disease agents, including the virus SARS-CoV-2, which causes the disease Covid-19, in indoor environments. Vivera’s BioZone is a unique, personal, whole-body sanitizing and thermal imaging system which perfectly complements our existing technology platforms by identifying potential carriers of COVID-19 and by providing whole body sanitization and personal identification.”
About Vivera Pharmaceuticals, Inc.
Vivera Pharmaceuticals, Inc., is an innovative, science-driven pharmaceutical company focused on novel therapies for a variety of indications. In addition to its pharmaceutical, medical device, medical supply, medical technologies, and health and human service divisions, the Company has global exclusivity to license the patented and patent-pending TABMELT® sublingual drug-delivery system for the pharmaceutical use of therapeutic compounds. Vivera is vertically integrated with patented technology, manufacturing capabilities, and distribution for its products. For more information please visit www.viverapharma.com, or email at Media@ViveraPharma.com
About EcoGroup USA
EcoGroup USA was established in 2018 on Long Island, NY, as a Personal Protection Equipment (PPE) company. In September 2020, EcoGroup USA began structuring the merger with STAT Holdings, LLC to expand the company’s geographic reach and product offerings, bringing on patented antimicrobial technologies, executive management (including the appointment of CEO Gregory Shiffner), a renowned group of scientists, PhDs, and healthcare experts with decades of experience.
EcoGroup USA’s mission is to create spaces in which employees, customers, clients, and residents will be safe from indoor air pathogens. Our technology partners have over 15 years of experience, our team of subject matter experts have been focused on the reduction of harmful viruses, bacteria, and microbes, including the Novel COVID 19 Virus.
Our product offerings feature innovative and emerging EPA registered products, including patented organic antimicrobial technologies manufactured in the US. Our flagship solution is ECOSENSE Platforms, a comprehensive IAQ System that features an antimicrobial UVGI approach proven to eliminate 99.9% of certain microbial germs on surfaces and in the air, including the SARS-COV-2 virus. We are a rapidly expanding company with corporate locations in Eatontown, NJ, Long Island, Staten Island and Charleston S.C. We have sales teams and strategic partners located across the US and our Research & Development teams are in Jupiter, FL as well as the Penn Center for Innovation located in Philadelphia, PA.
If you would like more information about this topic, please call 732.582.5717, or email at firstname.lastname@example.org